The Online Investor
Stock Buybacks
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
OPCH Buyback image

Option Care Health, Inc. Buyback

OLI recorded this information on 12/6/2023

Company: Option Care Health, Inc.
Buyback: OPCH buyback
$Amount Authorized: $500,000,000
Buyback Details: Option Care Health, Inc. (the "Company" or "Option Care Health") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today that it anticipates completing the remaining $75 million of repurchases in the fourth quarter under the original authorization. In addition, the Company's Board of Directors approved an increase to its share repurchase program authorization from $250 million to $500 million. The program has no specified expiration date.

Option Care Health is an independent provider of home and alternate site infusion services. Co.'s infusion services include the clinical management of infusion therapy, nursing support and care coordination. Co.'s team of clinicians, including pharmacists, pharmacy technicians, nurses and dietitians, are able to provide infusion service coverage for nearly all patients across the U.S. needing treatment for medical conditions. Co.'s services include: Anti-Infectives Infusion; Nutrition Support Infusion; Immunoglobulin Infusion; Chronic Inflammatory Disorders; Neurological Disorders; Bleeding Disorders Infusion; Women's Health; Heart Failure; and others.

OPCH SEC Filing Email Alerts Service

Open the OPCH Page at The Online Investor »

Company Name:  Option Care Health Inc
Stock buyback:  OPCH buyback
Website:  www.bioscrip.com
Sector:  Diagnostics
Number of ETFs Holding OPCH:  54
Total Market Value Held by ETFs:  $958.66M
Total Market Capitalization:  $5.26B
% of Market Cap. Held by ETFs:  18.23%
 

Open the OPCH Page at The Online Investor (in a new window) »

May 1, 2024    7:43 PM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree OPCH Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (4.00 out of 4)
83rd percentile
(ranked higher than approx. 83% of all stocks covered)

Analysts' Target Price:
OPCH Stock Forecast

Based on Zacks ABR data;
powered by Xignite

OPCH Buyback | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.